Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPHLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LTBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRERF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGAT4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORMDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NACC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928589 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RALBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP30L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on